Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-07-025134

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FRYKMAN EDWARD W · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2007-02-22 Grant or award : show line 1 in the form Stock Option +20,000 $3.93 2017-02-22 20,000 165,000 D
Loading xslF345X02/rrd154105.xml…